$433 Million is the total value of Eagle Health Investments LP's 27 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ARGX | ARGENX SEsponsored adr | $22,843,449 | +7.3% | 60,300 | 0.0% | 5.27% | +7.9% | |
SGEN | SEAGEN INC | $22,476,656 | -6.1% | 174,902 | 0.0% | 5.18% | -5.6% | |
CMAX | CAREMAX INC | $2,608,856 | -48.5% | 714,755 | 0.0% | 0.60% | -48.2% | |
TXG | 10X GENOMICS INC | $1,792,848 | +28.0% | 49,200 | 0.0% | 0.41% | +28.6% | |
BEAM | BEAM THERAPEUTICS INC | $1,130,279 | -17.9% | 28,900 | 0.0% | 0.26% | -17.4% | |
OLK | OLINK HLDG ABsponsored ads | $1,015,200 | +108.9% | 40,000 | 0.0% | 0.23% | +108.9% | |
ARVN | ARVINAS INC | $786,830 | -23.1% | 23,000 | 0.0% | 0.18% | -22.6% | |
BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $695,600 | +27.2% | 23,500 | 0.0% | 0.16% | +27.0% | |
LYEL | LYELL IMMUNOPHARMA INC | $347,000 | -52.7% | 100,000 | 0.0% | 0.08% | -52.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
NATERA INC | 12 | Q3 2023 | 8.5% |
ARGENX SE | 12 | Q3 2023 | 7.0% |
DEXCOM INC | 12 | Q3 2023 | 5.7% |
OUTSET MED INC | 12 | Q3 2023 | 7.3% |
AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-10-27 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-10 |
13F-HR | 2021-10-20 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.